These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 7770639)
1. Effects of ursodeoxycholic acid on hemodynamic and renal function abnormalities induced by obstructive jaundice in rats. Poo JL; Estanes A; Pedraza-Chaverrí J; Cruz C; Uribe M Ren Fail; 1995 Jan; 17(1):13-20. PubMed ID: 7770639 [TBL] [Abstract][Full Text] [Related]
2. Ursodeoxycholic acid limits liver histologic alterations and portal hypertension induced by bile duct ligation in the rat. Poo JL; Feldmann G; Erlinger S; Braillon A; Gaudin C; Dumont M; Lebrec D Gastroenterology; 1992 May; 102(5):1752-9. PubMed ID: 1568585 [TBL] [Abstract][Full Text] [Related]
3. Effect of ursodeoxycholic acid administration on bile duct proliferation and cholestasis in bile duct ligated rat. Frezza EE; Gerunda GE; Plebani M; Galligioni A; Giacomini A; Neri D; Faccioli AM; Tiribelli C Dig Dis Sci; 1993 Jul; 38(7):1291-6. PubMed ID: 8325189 [TBL] [Abstract][Full Text] [Related]
4. Metabolism and effects on cholestasis of isoursodeoxycholic and ursodeoxycholic acids in bile duct ligated rats. Purucker E; Marschall HU; Winograd R; Matern S Biochim Biophys Acta; 2001 Apr; 1526(1):44-52. PubMed ID: 11287121 [TBL] [Abstract][Full Text] [Related]
5. Renal vasoactive mediator generation in portal hypertensive and bile duct ligated rats. Ackerman Z; Karmeli F; Amir G; Rachmilewitz D J Hepatol; 1996 Apr; 24(4):478-86. PubMed ID: 8738735 [TBL] [Abstract][Full Text] [Related]
6. Impaired renal function in obstructive jaundice: enhanced glomerular thromboxane synthesis and effects of thromboxane receptor blockade in bile duct-ligated rats. Kramer HJ; Schwarting K; Bäcker A Clin Sci (Lond); 1995 Jan; 88(1):39-45. PubMed ID: 7704998 [TBL] [Abstract][Full Text] [Related]
7. [Chronology of portal hypertension, decreased sodium excretion, and activation of the renin-angiotensin system in experimental biliary cirrhosis]. Poo JL; Estanes A; Pedraza-Chaverrí J; Cruz C; Pérez C; Huberman A; Uribe M Rev Invest Clin; 1997; 49(1):15-23. PubMed ID: 9229751 [TBL] [Abstract][Full Text] [Related]
8. NCX-1000, a nitric oxide-releasing derivative of ursodeoxycholic acid, ameliorates portal hypertension and lowers norepinephrine-induced intrahepatic resistance in the isolated and perfused rat liver. Fiorucci S; Antonelli E; Brancaleone V; Sanpaolo L; Orlandi S; Distrutti E; Acuto G; Clerici C; Baldoni M; Del Soldato P; Morelli A J Hepatol; 2003 Dec; 39(6):932-9. PubMed ID: 14642608 [TBL] [Abstract][Full Text] [Related]
9. Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis. Macias RI; Serrano MA; Monte MJ; Jimenez S; Hernandez B; Marin JJ J Pharmacol Exp Ther; 2005 Feb; 312(2):751-8. PubMed ID: 15452192 [TBL] [Abstract][Full Text] [Related]
10. Chronic administration of ursodeoxycholic acid decreases portal pressure in rats with biliary cirrhosis. Yang YY; Huang YT; Lee KC; Lee FY; Lee TY; Hou MC; Lin HC; Lee SD Clin Sci (Lond); 2009 Jan; 116(1):71-9. PubMed ID: 18479249 [TBL] [Abstract][Full Text] [Related]
11. Renal endothelin system in obstructive jaundice: its role in impaired renal function of bile-duct ligated rats. Kramer HJ; Schwarting K; Bäcker A; Meyer-Lehnert H Clin Sci (Lond); 1997 Jun; 92(6):579-85. PubMed ID: 9205418 [TBL] [Abstract][Full Text] [Related]
12. Protective effect of the intravenous administration of ursodeoxycholic acid against endotoxemia in rats with obstructive jaundice. Hori Y; Ohyanagi H Surg Today; 1997; 27(2):140-4. PubMed ID: 9017991 [TBL] [Abstract][Full Text] [Related]
13. Early colchicine administration reduces hepatic fibrosis and portal hypertension in rats with bile duct ligation. Poo JL; Feldmann G; Moreau A; Gaudin C; Lebrec D J Hepatol; 1993 Aug; 19(1):90-4. PubMed ID: 8301049 [TBL] [Abstract][Full Text] [Related]
14. Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles. Fickert P; Zollner G; Fuchsbichler A; Stumptner C; Weiglein AH; Lammert F; Marschall HU; Tsybrovskyy O; Zatloukal K; Denk H; Trauner M Gastroenterology; 2002 Oct; 123(4):1238-51. PubMed ID: 12360485 [TBL] [Abstract][Full Text] [Related]
15. Ursodeoxycholic acid alleviates cholestasis-induced histophysiological alterations in the male reproductive system of bile duct-ligated rats. Saad RA; Mahmoud YI Reprod Toxicol; 2014 Dec; 50():87-97. PubMed ID: 25461907 [TBL] [Abstract][Full Text] [Related]
16. Effects of ursodeoxycholic acid, glutamine and polyclonal immunoglobulins on bacterial translocation in common bile duct ligated rats. Aldemir M; Geyik MF; Kökoğlu OF; Büyükbayram H; Hoşoğlu S; Yağmur Y ANZ J Surg; 2003 Sep; 73(9):722-6. PubMed ID: 12956789 [TBL] [Abstract][Full Text] [Related]
17. Randomised post-test-only study of glutathione and ursodeoxycholic acid combination therapy on liver function in cholestasis-induced rats. Prasetyo AA; Rachmawati B; Riwanto I Med J Malaysia; 2024 Aug; 79(Suppl 4):63-67. PubMed ID: 39215417 [TBL] [Abstract][Full Text] [Related]
18. Antagonism of sphingosine 1-phosphate receptor 2 causes a selective reduction of portal vein pressure in bile duct-ligated rodents. Kageyama Y; Ikeda H; Watanabe N; Nagamine M; Kusumoto Y; Yashiro M; Satoh Y; Shimosawa T; Shinozaki K; Tomiya T; Inoue Y; Nishikawa T; Ohtomo N; Tanoue Y; Yokota H; Koyama T; Ishimaru K; Okamoto Y; Takuwa Y; Koike K; Yatomi Y Hepatology; 2012 Oct; 56(4):1427-38. PubMed ID: 22505286 [TBL] [Abstract][Full Text] [Related]
19. Hemodynamic characterization of chronic bile duct-ligated rats: effect of pentobarbital sodium. Lee SS; Girod C; Braillon A; Hadengue A; Lebrec D Am J Physiol; 1986 Aug; 251(2 Pt 1):G176-80. PubMed ID: 3740260 [TBL] [Abstract][Full Text] [Related]
20. Differential effects of norUDCA and UDCA in obstructive cholestasis in mice. Fickert P; Pollheimer MJ; Silbert D; Moustafa T; Halilbasic E; Krones E; Durchschein F; Thüringer A; Zollner G; Denk H; Trauner M J Hepatol; 2013 Jun; 58(6):1201-8. PubMed ID: 23369794 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]